Medicines included in EMLs are selected based on evidence of their safety, efficacy, and cost-effectiveness. The selection process involves rigorous assessment by experts and takes into account the disease burden, public health relevance, and the comparative advantages of the medicines. The goal is to ensure that the selected medicines provide the best possible health outcomes for the population.
